|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
5 terms
|
 |
|
Biological process
|
immune response
|
9 terms
|
 |
|
Biochemical function
|
protein binding
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
283:179-191
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120.
|
|
H.Li,
K.Natarajan,
E.L.Malchiodi,
D.H.Margulies,
R.A.Mariuzza.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of the mouse major histocompatibility complex (MHC) class
I molecule H-2Dd with an immunodominant peptide, designated P18-I10
(RGPGRAFVTI), from human immunodeficiency virus envelope glycoprotein 120 was
determined at 3.2 A resolution. A novel orientation of the alpha3 domain of Dd
relative to the alpha1/alpha2 domains results in significantly fewer contacts
between alpha3 and beta2-microglobulin compared with other MHC class I proteins.
Four out of ten peptide residues (P2 Gly, P3 Pro, P5 Arg and P10 Ile) are nearly
completely buried in the Dd binding groove. This is consistent with previous
findings that Dd exploits a four-residue binding motif comprising a glycine at
P2, a proline at P3, a positively charged residue at P5, and a C-terminal
hydrophobic residue at P9 or P10. The side-chain of P5 Arg is directed toward
the floor of the predominantly hydrophobic binding groove where it forms two
salt bridges and one hydrogen bond with Dd residue Asp77. The selection of
glycine at P2 appears to be due to a narrowing of the B pocket, relative to that
of other class I molecules, caused by Arg66 whose side-chain folds down into the
binding cleft. Residue P3 Pro of P18-I10 occupies part of pocket D, which in Dd
is partially split by a prominent hydrophobic ridge in the floor of the binding
groove formed by Trp97 and Trp114. Residues P6 through P9 form a solvent-exposed
bulge, with P7 Phe protruding the most from the binding groove and thereby
probably constituting a major site of interaction with T cell receptors. A
comparison of H-2Dd/P18-I10 with other MHC class I/peptide complexes of known
structure provides insights into the possible basis for the specificity of the
natural killer cell receptor Ly-49A for several related class I molecules.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Ribbon diagram of the H-2D^d/P18-I10 complex. The
a1, a2, a3 and b[2]m domains are labeled. All Figures were
generated by MOLSCRIPT [Kraulis 1991] and Raster3D [Bacon and
Anderson 1988 and Merritt and Bacon 1997] if not specified.
|
 |
Figure 6.
Figure 6. Location of H-2D^dresidues implicated in binding
the NK inhibitory receptor Ly-49A. The P18-I10 peptide is
yellow; the a1 and a2 domains of D^dare labeled. In pink are
residues of in the a1 domain and N-terminal portion of the a2
domain of D^dthat differ in D^b. In blue are D^dresidues that
have different side-chain conformations in Kb, Ldor D^b. In red
is the N-terminal part of the a2 domain of D^d(residues 90 to
107).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1998,
283,
179-191)
copyright 1998.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Honda,
R.Wang,
W.P.Kong,
M.Kanekiyo,
W.Akahata,
L.Xu,
K.Matsuo,
K.Natarajan,
H.Robinson,
T.E.Asher,
D.A.Price,
D.C.Douek,
D.H.Margulies,
and
G.J.Nabel
(2009).
Different vaccine vectors delivering the same antigen elicit CD8+ T cell responses with distinct clonotype and epitope specificity.
|
| |
J Immunol, 183,
2425-2434.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Wang,
K.Natarajan,
and
D.H.Margulies
(2009).
Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.
|
| |
J Immunol, 183,
2554-2564.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Sidney,
B.Peters,
N.Frahm,
C.Brander,
and
A.Sette
(2008).
HLA class I supertypes: a revised and updated classification.
|
| |
BMC Immunol, 9,
1.
|
 |
|
|
|
|
 |
A.Azizi,
and
F.Diaz-Mitoma
(2007).
Viral peptide immunogens: current challenges and opportunities.
|
| |
J Pept Sci, 13,
776-786.
|
 |
|
|
|
|
 |
T.Ishigaki,
I.Ohki,
T.Oyama,
S.Machida,
K.Morikawa,
and
S.Tate
(2005).
Purification, crystallization and preliminary X-ray analysis of the ligand-binding domain of human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 61,
524-527.
|
 |
|
|
|
|
 |
Y.Wang,
A.Rubtsov,
R.Heiser,
J.White,
F.Crawford,
P.Marrack,
and
J.W.Kappler
(2005).
Using a baculovirus display library to identify MHC class I mimotopes.
|
| |
Proc Natl Acad Sci U S A, 102,
2476-2481.
|
 |
|
|
|
|
 |
R.C.Hillig,
M.Hülsmeyer,
W.Saenger,
K.Welfle,
R.Misselwitz,
H.Welfle,
C.Kozerski,
A.Volz,
B.Uchanska-Ziegler,
and
A.Ziegler
(2004).
Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association.
|
| |
J Biol Chem, 279,
652-663.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Samino,
D.Lopez,
S.Guil,
P.de León,
and
M.Del Val
(2004).
An endogenous HIV envelope-derived peptide without the terminal NH3+ group anchor is physiologically presented by major histocompatibility complex class I molecules.
|
| |
J Biol Chem, 279,
1151-1160.
|
 |
|
|
|
|
 |
D.M.Hill,
T.Kasliwal,
E.Schwarz,
A.M.Hebert,
T.Chen,
E.Gubina,
L.Zhang,
and
S.Kozlowski
(2003).
A dominant negative mutant beta 2-microglobulin blocks the extracellular folding of a major histocompatibility complex class I heavy chain.
|
| |
J Biol Chem, 278,
5630-5638.
|
 |
|
|
|
|
 |
V.Khammanivong,
X.S.Liu,
W.J.Liu,
S.J.Rodda,
G.R.Leggatt,
R.W.Tindle,
I.H.Frazer,
and
G.J.Fernando
(2003).
Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16.
|
| |
Immunol Cell Biol, 81,
1-7.
|
 |
|
|
|
|
 |
P.K.Hocknell,
R.D.Wiley,
X.Wang,
T.G.Evans,
W.J.Bowers,
T.Hanke,
H.J.Federoff,
and
S.Dewhurst
(2002).
Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses.
|
| |
J Virol, 76,
5565-5580.
|
 |
|
|
|
|
 |
N.Matsumoto,
M.Mitsuki,
K.Tajima,
W.M.Yokoyama,
and
K.Yamamoto
(2001).
The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand.
|
| |
J Exp Med, 193,
147-158.
|
 |
|
|
|
|
 |
A.Simon,
Z.Dosztányi,
E.Rajnavölgyi,
and
I.Simon
(2000).
Function-related regulation of the stability of MHC proteins.
|
| |
Biophys J, 79,
2305-2313.
|
 |
|
|
|
|
 |
H.Toh,
C.J.Savoie,
N.Kamikawaji,
S.Muta,
T.Sasazuki,
and
S.Kuhara
(2000).
Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
|
| |
Biopolymers, 54,
318-327.
|
 |
|
|
|
|
 |
J.E.Slansky,
F.M.Rattis,
L.F.Boyd,
T.Fahmy,
E.M.Jaffee,
J.P.Schneck,
D.H.Margulies,
and
D.M.Pardoll
(2000).
Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.
|
| |
Immunity, 13,
529-538.
|
 |
|
|
|
|
 |
M.C.Nakamura,
S.Hayashi,
E.C.Niemi,
J.C.Ryan,
and
W.E.Seaman
(2000).
Activating Ly-49D and inhibitory Ly-49A natural killer cell receptors demonstrate distinct requirements for interaction with H2-D(d).
|
| |
J Exp Med, 192,
447-454.
|
 |
|
|
|
|
 |
K.Maenaka,
and
E.Y.Jones
(1999).
MHC superfamily structure and the immune system.
|
| |
Curr Opin Struct Biol, 9,
745-753.
|
 |
|
|
|
|
 |
K.Natarajan,
L.F.Boyd,
P.Schuck,
W.M.Yokoyama,
D.Eliat,
and
D.H.Margulies
(1999).
Interaction of the NK cell inhibitory receptor Ly49A with H-2Dd: identification of a site distinct from the TCR site.
|
| |
Immunity, 11,
591-601.
|
 |
|
|
|
|
 |
Q.R.Fan,
and
D.C.Wiley
(1999).
Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor.
|
| |
J Exp Med, 190,
113-123.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|